| Literature DB >> 16630219 |
F Wandroo1, P Stableforth, Y Hasan.
Abstract
Cerebral aspergillosis is associated with very high mortality in immunocompromised hosts. Conventional antifungal agents like amphotericin-B and itraconazole are almost ineffective in cerebral aspergillosis. Newer azoles have been shown to penetrate the blood, cerebrospinal fluid barrier and achieve effective fungicidal concentrations. These newer azoles may change the outlook of this fatal condition. We report here a patient with cerebral aspergillosis who was successfully treated with voriconazole.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16630219 DOI： 10.1111/j.1365-2257.2006.00737.x
Source DB: PubMed Journal: Clin Lab Haematol ISSN： 0141-9854